Health Trials

Can COX-2 Inhibitor Decrease Stricture Recurrence After Direct Vision Internal Urethrotomy?

ConditionsCOX-2 InhibitorMeloxicamStricture RecurrenceDirect Vision Internal Urethrotomy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18+
SponsorNew Valley University

About this trial

To evaluate the efficacy and safety of nonsteroidal anti-inflammatory drugs (NSAIDs) in preventing urethral stricture recurrence after direct visual internal urethrotomy.

Eligibility criteria

Qualifiers

Age ≥ 18 years

American Society of Anesthesiologists (ASA) score ≤3.

Urethral stricture length ≤ 1.5 cm

Disqualifiers

Recurrent urethral stricture ≥ 2 times.

Pelvic fracture urethral distraction defect (PFUDD).

Trial design

Treatments tested in this trial

  • Nonsteroidal anti-inflammatory drugs
  • Placebo

Treatment groups

82 Participants
are divided into 2 treatment groups

Locations

1

Map coordinates are unavailable for these locations. Locations are shown below instead.

New Valley UniversityRecruiting72511, New Valley, New Valley GovernorateEgyptEgypt

Sponsors and collaborators

New Valley University

Lead sponsor

Source ClinicalTrials.gov